The Division of Oncology and the Brain Tumor Center (BTC) at Washington University in St. Louis seeks candidates for a faculty position at the Associate/Professor level to lead the clinical trials program in Neuro-Oncology as Medical Director of the BTC. The Division of Oncology and the BTC have outstanding resources, a collegial working environment, an impressive track record of clinical, translational, and basic research, and a well-organized clinical and research infrastructure. The Alvin J Siteman Cancer Center (SCC) at Washington University is one of the top cancer centers in the country, with Exceptional ratings from the National Cancer Institute over the past decade.
Over the past 10 years, we have recruited and assembled a team of world-class neurosurgeons, medical oncologists, radiation oncologists, neurologists, neuroradiologists, neuropathologists, and neuroscientists dedicated to developing novel therapies and technologies to ultimately cure brain cancer. The evolution of our expertise in the science and treatment of brain cancers is the direct result of intentional efforts by the cornerstone institutions on our campus—Washington University School of Medicine, Siteman Cancer Center, and BJC HealthCare—to establish a world-class brain tumor program. The establishment of the BTC reflects an important and strategic redirection of resources and programmatic emphasis at Washington University and BJC. Today, our rapidly expanding brain tumor team includes >30 investigators from 9 different departments. We are looking for someone with clinical/translational expertise in Neuro-Oncology to build and expand clinical trials in Neuro-Oncology. This person will report to the leadership of the BTC and the Division of Oncology.
The BTC is centered within the vibrant community of Washington University School of Medicine in St. Louis—a global leader in cancer biology, neuroscience, immunology, molecular imaging, and high-speed comprehensive genomic and epigenetic research. Research laboratories from neurosurgery, medical and pediatric oncology, neurology, radiation oncology, neuroradiology, immunology & pathology, and genetics seek new treatments for the most common as well as rare brain tumors. By leveraging cutting-edge medical, surgical, and radiation technologies at the Alvin J. Siteman Comprehensive Cancer Center, one of the nation’s elite cancer research institutions, and Barnes-Jewish Hospital and St. Louis Children’s Hospital, our physicians and scientists have developed a broad-based clinical research portfolio with over 35 ongoing clinical trials.
Beginning in 2023, BTC research laboratories will be housed within the new $616 million, 11-story and 609,000 square-foot, state-of-the-art Neuroscience Research Building. The building project is not only the largest in the history of Washington University’s School of Medicine but will also represent one of the largest neuroscience-focused research structures in the country, spanning almost a block in the 200-acre CORTEX Innovation Community—one of the fastest-growing business, innovation, and technology hubs in the United States. This infrastructure will enable and strengthen collaborations between academic research and industry partners to rapidly translate fundamental science into advanced care for brain tumor patients.
The physician will have outstanding support from nurse coordinators and nurse practitioners; weekend and evening calls are covered by an independent team of providers. Access to clinical trials is a significant strength. Washington University has well over 500 clinical trials for patients with various malignancies. Physicians also have access to experts in various disciplines.
As an integral part of the educational mission, the faculty members will actively participate in the teaching of fellows, residents, and medical students. Candidates must have an MD or equivalent, be board-eligible or board-certified in Medical Oncology and/or Neurology, and fellowship trained in neuro-oncology by the appointment start date.
Located in St. Louis, Washington University Division of Oncology/Siteman Cancer Center is the only center in Missouri and a surrounding 250-mile radius to be designated a Comprehensive Cancer Center by the National Cancer Institute (NCI). It has also been awarded the NCI “Exceptional” rating, the highest designation for cancer research programs available. The metropolitan area has a population exceeding 2.8 million people and our diversified economy is home to corporate headquarters and major business divisions across a range of industries. Some notable companies that consider St. Louis home include Centene, Emerson Electric, Reinsurance Group of America, Edward Jones, Energizer Holdings, Express Scripts, Post Holdings, Graybar Electric, and Bunge, just to name a few. U.S. News ranked St. Louis the 25th most affordable place to live in the U.S in 2022-2023 based on median gross rents and annual housing cost. In addition, the city also boasts 149 private schools and 278 public schools serving 32,644 and 105,238 students respectively. The city is also home to the St. Louis Cardinals baseball team and the Blues hockey franchise.
In addition to CORTEX, a vibrant innovation hub and technology district integrated into St. Louis’ historic Central West End and Forest Park Southeast residential neighborhoods and adjacent to the Medical Center campus, St. Louis is host to more than 100 different pharmaceutical and biotechnology companies, many of which (approximately 80%) were founded by WU faculty, staff, and alumni. The 1,200% growth rate of the St. Louis technology hub is almost double that of its closest follower (Munich, Germany).
Washington University is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment regardless of race, color, religion, age, sex, sexual orientation, gender identity or expression, national origin, genetic information, disability, or protected veteran status.
For assistance regarding the application process, please contact Erin True, Special Projects Administrator (email@example.com) with a CV and a cover letter. The selected candidate will be required to complete a background check at the time of recruitment.